BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 27780698)

  • 21. Outcomes of fertility-sparing surgery for stage II and III serous borderline ovarian tumors.
    Lu Z; Li B; Gu C
    J Int Med Res; 2019 Oct; 47(10):4895-4903. PubMed ID: 31432738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian Low-grade Serous Carcinoma: A Clinicopathologic Study of 33 Cases With Primary Surgery Performed at a Single Institution.
    Okoye E; Euscher ED; Malpica A
    Am J Surg Pathol; 2016 May; 40(5):627-35. PubMed ID: 26900814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fertility-sparing treatment in advanced-stage serous borderline ovarian tumors. An analysis from the MITO14 study database.
    Falcone F; Breda E; Ferrandina G; Malzoni M; Perrone AM; Cormio G; Di Donato V; Frigerio L; Mangili G; Raspagliesi F; Festi A; Scibilia G; Biglia N; Sorio R; Vizza E; Losito NS; Greggi S
    Gynecol Oncol; 2021 Jun; 161(3):825-831. PubMed ID: 33781554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nomogram to predict live birth rate after fertility-sparing surgery for borderline ovarian tumours.
    Ouldamer L; Bendifallah S; Naoura I; Body G; Uzan C; Morice P; Ballester M; Daraï E
    Hum Reprod; 2016 Aug; 31(8):1732-7. PubMed ID: 27496944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Staging procedures fail to benefit women with borderline ovarian tumours who want to preserve fertility: a retrospective analysis of 448 cases.
    Li N; Gou J; Li L; Ming X; Hu TW; Li Z
    BMC Cancer; 2020 Aug; 20(1):769. PubMed ID: 32807135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fertility determinants after conservative surgery for mucinous borderline tumours of the ovary (excluding peritoneal pseudomyxoma).
    Koskas M; Uzan C; Gouy S; Pautier P; Lhommé C; Haie-Meder C; Duvillard P; Morice P
    Hum Reprod; 2011 Apr; 26(4):808-14. PubMed ID: 21262776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Borderline ovarian tumours.
    Tropé CG; Kaern J; Davidson B
    Best Pract Res Clin Obstet Gynaecol; 2012 Jun; 26(3):325-36. PubMed ID: 22321906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of fertility-sparing surgery and further prognostic factors in borderline tumors of the ovary.
    Westermann T; Karabeg E; Heitz F; Traut A; Plett H; Moubarak M; Welz J; Heikaus S; Lax S; du Bois A; Harter P
    Int J Gynecol Cancer; 2024 Jun; 34(6):898-905. PubMed ID: 38627034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Epidemiology and Risk Factors of Relapse, Follow-up and Interest of a Completion Surgery].
    Margueritte F; Sallee C; Lacorre A; Gauroy E; Larouzee E; Chereau E; De La Motte Rouge T; Koskas M; Gauthier T
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):248-259. PubMed ID: 32004784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fertility preserving surgical treatment of borderline ovarian tumour: long-term consequence for fertility and recurrence.
    Marcickiewicz J; Brännström M
    Acta Obstet Gynecol Scand; 2006; 85(12):1496-500. PubMed ID: 17260228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Retrospective analysis of the clinical outcomes in 12 recurrent borderline ovarian tumor patients with second fertility-sparing surgery].
    Chen R; Zhu T; Yu H; Zhu J; Lu X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Apr; 49(4):254-9. PubMed ID: 24969331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?
    Chiesa AG; Deavers MT; Veras E; Silva EG; Gershenson D; Malpica A
    Int J Gynecol Pathol; 2010 Mar; 29(2):108-12. PubMed ID: 20173495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes after Fertility-sparing Surgery for Women with Ovarian Cancer: A Systematic Review of the Literature.
    Bercow A; Nitecki R; Brady PC; Rauh-Hain JA
    J Minim Invasive Gynecol; 2021 Mar; 28(3):527-536.e1. PubMed ID: 32861046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients.
    Bentivegna E; Fruscio R; Roussin S; Ceppi L; Satoh T; Kajiyama H; Uzan C; Colombo N; Gouy S; Morice P
    Fertil Steril; 2015 Nov; 104(5):1319-24. PubMed ID: 26149354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncofertility outcomes after fertility-sparing treatment of bilateral serous borderline ovarian tumors: results of a large retrospective study.
    Jia SZ; Xiang Y; Yang JJ; Shi JH; Jia CW; Leng JH
    Hum Reprod; 2020 Feb; 35(2):328-339. PubMed ID: 32048711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Borderline ovarian tumours: retrospective analysis of twenty-one cases.
    Saygili U; Uslu T; Erten O; Doğan E
    Eur J Gynaecol Oncol; 1998; 19(2):182-5. PubMed ID: 9611063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fertility-sparing surgery in children and adolescents with borderline ovarian tumors: a retrospective study.
    Zhao J; Wang D; Wang R; He Y; Jia C; Pan L; Ma S; Wu M; Wang W; Cheng X; Yang J; Xiang Y
    J Ovarian Res; 2024 May; 17(1):96. PubMed ID: 38720349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salpingo-oophorectomy versus cystectomy in patients with borderline ovarian tumors: a systemic review and meta-analysis on postoperative recurrence and fertility.
    Wang P; Fang L
    World J Surg Oncol; 2021 Apr; 19(1):132. PubMed ID: 33882931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery.
    Delle Marchette M; Ceppi L; Andreano A; Bonazzi CM; Buda A; Grassi T; Giuliani D; Sina F; Lamanna M; Bianchi T; Lissoni AA; Landoni F; Valsecchi MG; Fruscio R
    Eur J Cancer; 2019 Apr; 111():61-68. PubMed ID: 30826658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of borderline tumors of the ovary: state of the art.
    Tropé C; Kaern J
    Semin Oncol; 1998 Jun; 25(3):372-80. PubMed ID: 9633850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.